 |
| Photo file from Manila Times (ctto) |
Manila, Philippines – Another child who had been a receiver of
Dengvaxia died in Parañaque city on Sunday.
Volunteers Against Crime and Corruption (VACC) confirms the
news, but no further details yet were provided.
Dante Jimenez, chairman of the group, said that the latest
victim was a student between 9 and 11 years old.
Should the findings confirm dengue as the cause of death, the
child would be the second recorded casualty of Dengvaxia vaccine in Metro
Manila.
“The victim died today in Parañaque, but we could not give
further details about the child out of respect to the family,” Jimenez told the
Manila Times in an interview.
The child, reportedly, died months after injected with the dengue
vaccine under the immunization program conducted by the Department of Health
(DOH).
“We will request the PAO (Public Attorney’s Office) forensic
to conduct forensic examination on the victim to determine if the death is
linked to Dengvaxia,” Jimenez said.
There were seven victims examined by PAO, whose death were possibly
caused by the anti-Dengue vaccine produced by Sanofi – one the pharmaceutical
giants in the world.
So far, identified victims of the vaccine were from the provinces
of Bataan, Laguna, Cavite and Bulacan.
According to PAO forensics, in the seven examinations they
have conducted on the victims, the common findings were extensive bleeding and
enlarged organs.
It was during the administration of former President Benigno
Aquino 3rd that Department of Health launched the school-based
anti-dengue vaccination program in 2016, where in 850, 000 students were injected.
In November last year, Sanofi announced and admitted that Dengvaxia
could increase risk of severe dengue on individuals who have not been
previously infected with the disease.
0 Comments